Latest in News & Research

Review: Oral Isotretinoin Is Best Treatment for Acne

Meta-analysis reveals triple therapies containing topical retinoid, benzoyl peroxide, and antibiotic are next best

By Lori Solomon (HealthDay News) | | July 27, 2023

Variants at Two Loci Associated With Hidradenitis Suppurativa Risk

Two hidradenitis suppurativa-associated loci identified in meta-analysis of four studies, with variants located near SOX9 and KLF5 genes

By Dermsquared Editorial Team | | July 27, 2023

Incidence, Detection of Melanoma Low in Racial, Ethnic Minorities

Number needed to screen >12,000 in racial and ethnic minority individuals compared with 373 in non-Hispanic Whites

By Dermsquared Editorial Team | | July 26, 2023

LAUNCH ALERT: FDA Approves YCANTH for Molluscum Contagiosum

The groundbreaking topical solution addresses one of dermatology’s greatest unmet needs

By Dermsquared Editorial Team | | July 25, 2023

Melanoma Presentation, Mortality Varies by Race

Black patients face higher mortality with melanoma independent of insurance status and severity at diagnosis

By Lori Solomon (HealthDay News) | | July 24, 2023

Incidence Rate of Diagnosed Vitiligo 22.6 per 100,000 Person-Years

Vitiligo most commonly diagnosed in older adults and in Hispanic/Latino and Asian American patients

By Elana Gotkine (HealthDay News) | | July 24, 2023

JAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia

Study shows safety and tolerability of JAK inhibitors acceptable

By HealthDay News | | July 19, 2023

Skin Lightening Prevalent Among 'Skin of Color' Individuals

Skin lightening agent users have significantly higher composite colorism scores than nonusers

By HealthDay News | | July 19, 2023

Is Lymecycline Superior to Doxycycline for Moderate-to-Severe Acne?

Lymecycline led to earlier reduction in number of lesions and severity of acne; shorter duration of therapy needed with lymecycline

By Dermsquared Editorial Team | | July 19, 2023

Do Organ Transplant Recipients With cSCC Have Worse Outcomes?

Transplant recipients have increased rates of second cutaneous squamous cell carcinoma, metastasis, death from cutaneous squamous cell carcinoma

By Dermsquared Editorial Team | | July 19, 2023

Exploring the Comorbidities Associated with Vitiligo

Comorbidities associated with vitiligo go beyond just the skin, making it vital that clinicians consider these associated conditions to ensure comprehensive care for their...

By Dylan Maldonado, MD | | July 13, 2023

Prevalence of Atopic Diseases Increased in Sexually Diverse Individuals

Prevalence of atopic dermatitis, asthma, and allergic rhinitis increased compared with heterosexual individuals

By HealthDay News | | July 12, 2023

Confirmatory Testing Underused for Tinea Capitis Diagnosis

Testing significantly less likely when diagnosis made by pediatrician, family practice clinicians

By HealthDay News | | July 12, 2023

How Well Does 20 Percent Oxybutynin Hydrochloride Lotion Cut Palmar Sweat Volume?

20 percent oxybutynin hydrochloride lotion more effective than placebo for patients aged 12 years and older with primary palmar hyperhidrosis

By Dermsquared Editorial Team | | July 12, 2023

Contributory Factors Identified for Discordant Severity Grading for Eczema, Psoriasis

Higher patient-graded severity for eczema, psoriasis linked to higher symptom expression, greater quality-of-life impairment

By Dermsquared Editorial Team | | July 12, 2023

Lower Extremities Have Highest Surgical Site Infection Rates With Mohs Surgery

Findings especially for flap and graft closures

By HealthDay News | | July 05, 2023

Chemotherapy-Induced Pseudocellulitis Described in Case Reports

Cases of true chemo-induced pseudocellulitis resembled infectious cellulitis; did not meet diagnostic criteria for known diagnoses

By HealthDay News | | July 05, 2023

How Efficacious Is Microencapsulated BPO/Tretinoin for Acne?

Two studies show significant improvement in achieving Investigator Global Assessment success and change in inflammatory lesion count from baseline

By Dermsquared Editorial Team | | July 05, 2023

Does Addiction Risk Affect Patient Choice of Pain Meds After Mohs Surgery?

Half of patients with pain level of 6.5 of 10 expressed preference for OTCs plus opioids when theoretical risk of addiction was low

By Dermsquared Editorial Team | | July 05, 2023

Advancements in Treating Vitiligo

An overview of new and emerging treatments and research in vitiligo

By Jenny She [1], Stephen Moore [1], Harrison P. Nguyen [1,2] | | July 01, 2023

Research Roundup: Vitiligo

Everything you need to know this month to stay up to date on the latest research in vitiligo

By Dermsquared Editorial Team | | July 01, 2023

What’s New and Hot in Vitiligo

Treatment of vitiligo can be challenging, but with promising new treatments emerging, the therapeutic options for patients are increasing

By Jeanette Zambito, MD, MS | | July 01, 2023

Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema

Longer median time of flare-free maintenance, greater number of flare-free days, and lower mean number of flares

By HealthDay News | | June 28, 2023

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026